Skip to main content
TipRanks
Go Ultimate75% OFF

Bio-Techne (TECH) Revenue by Geography

536 Followers

Revenue by Geography

Bio-Techne reported revenue by region of $316.96M in Q4 FY2025, up 0.2% from Q3 FY2025 and up 3.5% year over year. This is the highest value since 2020.

Breaks down sales across regions so you can see where the company’s demand is strongest and where it faces exposure to local economic cycles, regulatory changes, or currency swings. Helps gauge geographic diversification and where future growth or risk is concentrated.

$0.00$50.00M$100.00M$150.00M$200.00M$250.00M$300.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25
Chart Insights

Bio-Techne's revenue growth in the United States and EMEA regions remains robust, reflecting strong demand in biopharma markets. Greater China shows signs of recovery with low double-digit growth, aligning with earnings call optimism about stabilization. However, the Rest of World and UK regions face challenges, possibly due to geopolitical and funding uncertainties. The strategic divestiture of Exosome Diagnostics is expected to enhance margins, supporting future profitability despite current market uncertainties.

No longer reported by the company (last reported Q4 FY2025)

TECH Revenue by Geography

PeriodUnited StatesGreater ChinaRest of WorldUnited KingdomEurope, Middle East, and Africa (excluding UK)APAC (excluding Greater China)Total
Q4 FY2025Jun 30, 2025$176.39M$26.91M$9.65M$14.79M$70.35M$18.89M$316.96M
Q3 FY2025Mar 31, 2025$181.92M$24.48M$9.18M$12.85M$66.50M$21.25M$316.18M
Q2 FY2025Dec 31, 2024$159.91M$24.75M$9.73M$13.24M$70.39M$19.01M$297.03M
Q1 FY2025Sep 30, 2024$165.01M$24.32M$8.99M$13.94M$59.06M$18.12M$289.46M
Q4 FY2024Jun 30, 2024$177.53M$23.93M$10.05M$11.77M$63.56M$19.26M$306.10M
Q3 FY2024Mar 31, 2024$173.31M$25.60M$10.61M$15.12M$60.53M$18.25M$303.43M
Q2 FY2024Dec 31, 2023$147.79M$24.46M$8.09M$10.68M$62.54M$19.04M$272.60M
Q1 FY2024Sep 30, 2023$159.10M$25.48M$7.75M$12.45M$54.80M$17.35M$276.94M
Q4 FY2023Jun 30, 2023$174.83M$25.77M$10.07M$13.07M$59.98M$17.60M$301.32M
Q3 FY2023Mar 31, 2023$163.20M$26.26M$11.02M$13.81M$59.70M$20.16M$294.15M
Q2 FY2023Dec 31, 2022$149.00M$30.33M$8.89M$10.87M$54.52M$17.97M$271.58M
Q1 FY2023Sep 30, 2022$155.43M$31.52M$7.51M$11.70M$46.02M$17.46M$269.65M
Q4 FY2022Jun 30, 2022$167.06M$26.44M$10.34M$11.40M$55.05M$17.93M$288.23M
Q3 FY2022Mar 31, 2022$163.98M$26.55M$10.53M$12.92M$55.30M$21.10M$290.38M
Q2 FY2022Dec 31, 2021$142.37M$31.01M$7.30M$11.84M$57.16M$19.60M$269.28M
Q1 FY2022Sep 30, 2021$140.70M$28.43M$7.06M$12.48M$51.54M$17.50M$257.72M
Q4 FY2021Jun 30, 2021$142.49M$23.87M$8.40M$11.35M$56.64M$16.27M$259.03M
Q3 FY2021Mar 31, 2021$131.59M$20.47M$6.73M$11.21M$54.55M$19.00M$243.55M
Q2 FY2021Dec 31, 2020$114.44M$25.16M$6.85M$9.85M$49.94M$18.01M$224.25M
Q1 FY2021Sep 30, 2020$113.56M$18.05M$5.18M$8.53M$43.13M$15.73M$204.20M

Related KPIs